Look At Analyst Expectations For A Better Read On Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)
BlackRock Fund Advisors recently announced the acquisition of new stake in Lexicon Pharmaceuticals Inc (NASDAQ:LXRX). The institutional investor has increased its shareholding in the Healthcare company by 4.54% to 5.98 million shares with purchase of 0.26 million shares. This fresh investment now brings its stake to 2.44% valued currently at $9.15 million. In addition, Millennium […]
There Is Clear Momentum For Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on 01/04/24 at a closing price of $1.60, with 3.35 million shares of worth about $5.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -27.93% during that period and on Thursday the price saw a gain of […]
Lexicon Pharmaceuticals Inc (LXRX): Not A Time To Panic Nor Freeze
BlackRock Fund Advisors has recently announced that it has increased stake in Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) by 4.54%. After grabbing 5.98 million shares, the institutional investor is now in possession of 0.26 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 2.44% having worth around $6.34 million. Moreover, […]
